Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis ; volume:22 ; number:1 ; day:23 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (23.11.2020), 1-11, 12.2020
- Creator
-
Verstappen, M.
Niemantsverdriet, E.
Matthijssen, X. M. E.
Cessie, S. le
Helm-van Mil, A. H. M. van der
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02368-9
- URN
-
urn:nbn:de:101:1-2021010319474461258479
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Verstappen, M.
- Niemantsverdriet, E.
- Matthijssen, X. M. E.
- Cessie, S. le
- Helm-van Mil, A. H. M. van der
- SpringerLink (Online service)
Other Objects (12)
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
On Maximizing the Probability of Achieving Deadlines in Communication Networks
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
On Maximizing the Probability of Achieving Deadlines in Communication Networks
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotrexate-based strategy
Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study